These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34452279)

  • 1. Recent Technologies for Amorphization of Poorly Water-Soluble Drugs.
    Kim DH; Kim YW; Tin YY; Soe MT; Ko BH; Park SJ; Lee JW
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.
    Budiman A; Lailasari E; Nurani NV; Yunita EN; Anastasya G; Aulia RN; Lestari IN; Subra L; Aulifa DL
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
    Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
    AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amorphization of Low Soluble Drug with Amino Acids to Improve Its Therapeutic Efficacy: a State-of-Art-Review.
    Kapoor DU; Singh S; Sharma P; Prajapati BG
    AAPS PharmSciTech; 2023 Dec; 24(8):253. PubMed ID: 38062314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave-Induced In Situ Amorphization: A New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions.
    Qiang W; Löbmann K; McCoy CP; Andrews GP; Zhao M
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32664477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
    Li Y; Rantanen J; Yang M; Bohr A
    Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.
    Forsgren J; Andersson M; Nilsson P; Mihranyan A
    Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study of the Pharmaceutical Properties between Amorphous Drugs Loaded-Mesoporous Silica and Pure Amorphous Drugs Prepared by Solvent Evaporation.
    Budiman A; Aulifa DL
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Glycerol as an Enabling Excipient for Microwave-Induced In Situ Drug Amorphization.
    Hempel NJ; Morsch F; Knopp MM; Berthelsen R; Löbmann K
    J Pharm Sci; 2021 Jan; 110(1):155-163. PubMed ID: 33058897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-phase amorphous-amorphous solid drug dispersion with enhanced stability, solubility and bioavailability resulting from ultrasonic dispersion of an immiscible system.
    Martínez LM; Videa M; López Silva T; Castro S; Caballero A; Lara-Díaz VJ; Castorena-Torres F
    Eur J Pharm Biopharm; 2017 Oct; 119():243-252. PubMed ID: 28648863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into the role of the polymer in enhancing microwave-induced in situ amorphization.
    Qiang W; Löbmann K; Knopp MM; McCoy CP; Andrews GP; Zhao M
    Int J Pharm; 2021 Nov; 609():121157. PubMed ID: 34626795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of poorly soluble compounds by amorphous solid dispersions.
    Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
    Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms.
    Ansari SR; Hempel NJ; Asad S; Svedlindh P; Bergström CAS; Löbmann K; Teleki A
    ACS Appl Mater Interfaces; 2022 May; 14(19):21978-21988. PubMed ID: 35452221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of solid thermolytic salts to facilitate microwave-induced in situ amorphization.
    Qiang W; Zhang M; Löbmann K; McCoy CP; Andrews GP; Zhao M
    Int J Pharm; 2024 Feb; 651():123791. PubMed ID: 38195031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drug and polymer particle size on the in situ amorphization using microwave irradiation.
    Hempel NJ; Knopp MM; Berthelsen R; Zeitler JA; Löbmann K
    Eur J Pharm Biopharm; 2020 Apr; 149():77-84. PubMed ID: 32035238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
    Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
    Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotic pump tablets with solid dispersions synergized by hydrophilic polymers and mesoporous silica improve in vitro/in vivo performance of cilostazol.
    Zhang S; Sun Y; Zhou L; Jiang Z; Yang X; Feng Y
    Int J Pharm; 2020 Oct; 588():119759. PubMed ID: 32800938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.